| |
> Agriculture
 > Human Health |
|
As our human health research and development program progresses, health care and biopharmaceutical companies will become our next targeted group of licensees. In a manner similar to the Agriculture Commercialization strategy, we intend to partner with companies capable of determining our technology’s ability to treat a broad range of diseases. This treatment could come in the form of a pharmaceutical, a direct therapy or some other means of delivery. It is our intention to participate in the research and development and to ultimately reap financial returns in the form of licensing fees and royalties on sales by our partners.
We are still in the process of developing a broad range of preclinical data on the role of our technology in certain diseases, independent of any partners. For more information please refer to Our Technology.
|
